Similar articles

• [Paclitaxel for treatment of advanced breast cancers].

  Ito Y. Ito Y. Nihon Rinsho. 2000 Apr;58 Suppl:259-64. Nihon Rinsho. 2000. PMID: 11026004 Review. Japanese. No abstract available.
• Role of paclitaxel in the treatment of breast cancer: the American Cooperative Group Experience.

  Sledge GW Jr. Sledge GW Jr. Semin Oncol. 1996 Feb;23(1 Suppl 1):10-2. Semin Oncol. 1996. PMID: 8629029 Review.
• [Docetaxel hydrate for treatment of advanced breast cancers].

  Fujii H. Fujii H. Nihon Rinsho. 2000 Apr;58 Suppl:254-8. Nihon Rinsho. 2000. PMID: 11026003 Review. Japanese. No abstract available.
• Neoadjuvant chemotherapy with weekly paclitaxel in breast cancer patients may increase release of cancer cells into circulation by decreasing interstitial fluid pressure.

  Altundag O, Altundag K, Gundeslioglu O, Silay YS, Ersoy Y. Altundag O, et al. Med Hypotheses. 2006;66(4):857-8. doi: 10.1016/j.mehy.2005.06.003. Epub 2005 Jul 20. Med Hypotheses. 2006. PMID: 16039067 No abstract available.
• Dose-intense paclitaxel: deja vu all over again?

  Takimoto CH, Rowinsky EK. Takimoto CH, et al. J Clin Oncol. 2003 Aug 1;21(15):2810-4. doi: 10.1200/JCO.2003.05.099. Epub 2003 Jun 13. J Clin Oncol. 2003. PMID: 12807932 No abstract available.